Deep phenotyping of blood cell data reveals novel clinical biomarkers

Clin Chem Lab Med. 2026 Oct 28. doi: 10.1515/cclm-2026-0822. Online ahead of print.ABSTRACTOBJECTIVES: The complete blood count with differential (CBD) is one of the most common blood tests worldwide. Although modern CBD analyzers generate flow-cytometry based single-cell measurements, the resultant

Y Ya-Lin Chen

PCSK9 and Atrial Fibrillation: A New Perspective on an Old Problem

Cardiovasc Ther. 2026;2026(1):e7328020. doi: 10.1155/cdr/7328020.ABSTRACTProprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a novel contributor to atrial fibrillation (AF) pathophysiology. Recent studies suggest that elevated PCSK9 levels may promote AF through multiple mechanisms,

A Amirhossein Sahebkar

The 12 and 24 Months Results of the VMI-CFA Study, a Physician-Initiated Trial Investigating the Efficacy of the Vascular Mimetic Implant Supera Peripheral Stent System for the Treatment of the Common Femoral Artery

J Endovasc Ther. 2026 Oct 26:15266028261489158. doi: 10.1177/15266028261489158. Online ahead of print.ABSTRACTOBJECTIVE: The objective of the Vascular Mimetic Implant-Common Femoral Artery Study (VMI-CFA) investigation is to evaluate the mid-term (24 months) outcome of treatment of the common femora

K Koen Deloose

Ubiquitin Protease Levels and Mitochondrial DNA Synthesis in Multiple Myeloma

Asian Pac J Cancer Prev. 2026 Oct 1;27(10):3517-3523. doi: 10.31557/APJCP.2026.27.10.3517.ABSTRACTOBJECTIVE: The deregulation of the ubiquitin system is linked to several disorders, including cancer, and is implicated in MM. The study aimed to determine serum β-catenin and UCHL1 concentration and re

W Wafaa Mahdi